Real-World Risk of Venous Thromboembolism with Bevacizumab Biosimilar versus Reference Biologic in Japanese Patients with Cancer: A Retrospective Cohort Study
Oncology and Therapy · 19.11.2026
DOI: 10.1007/s40487-026-00473-4 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Oncology and Therapy, online erschienen am 19.11.2026. Verfasst von Nobuhiro Ooba und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacoepidemiology, Nihon University School of Pharmacy, Funabashi, Chiba, Japan. ooba.nobuhiro@nihon-u.ac.jp. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Nippon Kayaku.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacoepidemiology, Nihon University School of Pharmacy, Funabashi, Chiba, Japan. ooba.nobuhiro@nihon-u.ac.jp.
- Department of Public Health and Epidemiology, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan.
- Quality and Pharmacovigilance Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd, Chiyoda, Tokyo, Japan.
- Clinical Development & Medical Affairs Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd, Chiyoda, Tokyo, Japan.
- Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.
Förderung
- Nippon Kayaku
Zitieren
APA
Ooba, N., Sakai, R., Sekine, K., Kanno, Y., Ishizuka, O., Hirai, T., & Taniguchi, H. (2026). Real-World Risk of Venous Thromboembolism with Bevacizumab Biosimilar versus Reference Biologic in Japanese Patients with Cancer: A Retrospective Cohort Study. Oncology and Therapy. https://doi.org/10.1007/s40487-026-00473-4
Vancouver
Ooba N, Sakai R, Sekine K, Kanno Y, Ishizuka O, Hirai T, et al. Real-World Risk of Venous Thromboembolism with Bevacizumab Biosimilar versus Reference Biologic in Japanese Patients with Cancer: A Retrospective Cohort Study. Oncology and Therapy. 2026. doi:10.1007/s40487-026-00473-4
BibTeX
@article{Ooba2026,
author = {Ooba, Nobuhiro and Sakai, Ryoko and Sekine, Keiko and Kanno, Yui and Ishizuka, Osamu and Hirai, Takayuki and Taniguchi, Hiroya},
title = {Real-World Risk of Venous Thromboembolism with Bevacizumab Biosimilar versus Reference Biologic in Japanese Patients with Cancer: A Retrospective Cohort Study},
journal = {Oncology and Therapy},
year = {2026},
doi = {10.1007/s40487-026-00473-4}
}
EUVIMED